Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid

NCT05906706 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Bullous Pemphigoid

Interventions

DRUG: dupilumab

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]